A blister-pack code is doing far more work than it ever should. Green Lumber Holdings is recalling Green Lumber Natural Fuel For Men, lot GL01 with expiration 09/27, after FDA laboratory analysis confirmed undeclared tadalafil in additional samples. The company says the consumer-level recall begins November 19, 2026. This is not a cute labeling nitpick or a marketing dispute. It is a medication-safety problem sitting inside a dietary supplement.
One Lot, But No Room for Casual Assumptions
The recalled item is a ten-capsule blister-pack supplement carrying UPC 8 60010 18290. The relevant lot number appears on the back of the blister pack. Green Lumber says GL01 was distributed from February 20 through August 31, 2026, sold directly to consumers through its own website, and shipped from its Costa Mesa, California warehouse. The company says it did not move through wholesalers, distributors, or retail stores.
That direct-to-consumer footprint narrows the distribution trail, at least on paper. Still, consumers should not confuse a narrower sales channel with a smaller safety obligation. The FDA updated its public notice on October 23 after confirming tadalafil in additional GL01 samples. “Additional samples” is the phrase that ought to stop anybody from playing amateur detective with package appearance, old online chatter, or a vague memory of when they bought it.
The Identifiers Matter More Than the Label Design
Green Lumber explicitly warns consumers not to rely on earlier lot-number exclusions or packaging comparisons as proof a product is safe. That warning deserves to be read twice. The company lists GL110725 EXP110727 and GL02 EXP05/29 as current codes not affected, but the instruction for anyone unsure is plain: stop using the product and contact the company. In a recall involving an undeclared drug ingredient, uncertainty is not a reason to take another capsule while somebody hunts through a bathroom drawer.
- Stop using Green Lumber Natural Fuel For Men if the blister pack is lot GL01 and expires 09/27.
- Keep the product rather than discarding it; Green Lumber says returns will be quarantined and destroyed in coordination with FDA.
- Known purchasers are expected to receive email notification and refund instructions.
- Anyone who used the product and experienced unexpected effects should contact a health care professional; serious symptoms warrant immediate medical care.
Tadalafil Changes the Risk Equation
Tadalafil is the active ingredient in the prescription drug Cialis, used to treat erectile dysfunction. Its presence was not declared on this supplement’s label. That distinction is the whole ballgame. Consumers choosing a supplement are not necessarily expecting a prescription-drug ingredient, its possible interactions, or the need for clinician oversight.
The stated concern is particularly serious for people taking nitrates, including nitroglycerin. Combining tadalafil with nitrates can lower blood pressure to dangerous levels. The notice also flags that people with diabetes, high blood pressure, high cholesterol, or heart disease often take nitrates. Nobody needs a lecture from a market watcher on their medical situation; they need to check the recalled lot, stop using it, and get professional guidance when there is any question.
What a Sector Watcher Should Take From This
There is no financial statement, public ticker, sales figure, or estimate of recall cost in the information provided. Green Lumber is identified as an LLC, so this is not a conventional public-equity earnings thesis. Trying to manufacture a stock angle out of a consumer safety alert would be cheap and beside the point.
But the broader supplement sector should not shrug this off. Hidden pharmaceutical ingredients are exactly the kind of failure that wrecks consumer trust because the downside is personal and immediate. A refund may settle the transaction; it cannot erase the anxiety created when somebody learns a product may contain a drug they never knew they were taking. For any business selling health-adjacent products, testing discipline, traceability, clear recall notices, and prompt consumer outreach are not bureaucratic ornaments. They are the minimum price of being trusted.
Green Lumber says it has received no reports of adverse events to date. That is worth noting, but it is not an all-clear siren. The company says it is taking FDA’s findings seriously and will provide further accurate information as details are confirmed. Fair enough. The practical message remains blunt: GL01, expiration 09/27, should be out of use until returned. On this one, caution beats wishful thinking by a mile.